Efficacy of oral fluconazole in tinea pedis of the hyperkeratotic type. Stratum corneum levels

Summary. In this study, in addition to studying the efficacy and safety of the once‐daily administration of 100‐mg capsules of fluconazole over an 8‐week administration period with six patients with hyperkeratotic‐type tinea pedis, we also measured the serum and horny layer concentrations of fluconazole to study the mobility into the horny layer in diseased areas of the sole skin. The final overall efficacy and overall safety were both 100% (six out of six), and no side‐effects, including abnormal‐laboratory changes, were observed in any of the patients. The drug mobility study revealed that in the horny layer of the skin a steady state was reached after 4 weeks of administration, with the mean concentration being 12.8μgg‐1. This concentration was a high concentration that was no less than 13 times the geometric mean MIC (0.972 μg ml‐1) for fresh clinical isolates of Trichophyton rubrum. Based on the above results, fluconazole is considered to be highly useful for treating various kinds of dermato‐mycosis, including hyperkeratotic‐type tinea pedis.

[1]  H. Yamaguchi,et al.  Preclinical Therapeutic Evaluation of Agents for Treating Dermatophytosis , 1996 .

[2]  M. Ollert,et al.  Results of German multicenter study of antimicrobial susceptibilities of Trichophyton rubrum and Trichophyton mentagrophytes strains causing tinea unguium. German Collaborative Dermatophyte Drug Susceptibility Study Group , 1995, Antimicrobial agents and chemotherapy.

[3]  T. Zimmermann,et al.  Bioavailability of fluconazole in the skin after oral medication , 1994, Mycoses.

[4]  J. Faergemann,et al.  Levels of fluconazole in serum, stratum corneum, epidermis‐dermis (without stratum corneum) and eccrine sweat , 1993, Clinical and experimental dermatology.

[5]  H. Degreef,et al.  Pharmacokinetic profile of orally administered itraconazole in human skin. , 1988, Journal of the American Academy of Dermatology.

[6]  Y. Nozawa,et al.  Selective Inhibitory Action of Fluconazole, an Antifungal Agent of Triazole-Derivative, on Sterol 14-C Demethylation of Candida albicans Cells , 1986 .

[7]  K. Nishimoto,et al.  Comparative study between potassium hydroxide mount and culture examinations during the treatment of dermatophytoses and candidiasis. , 1986 .

[8]  P. Troke,et al.  Activity of UK-49,858, a bis-triazole derivative, against experimental infections with Candida albicans and Trichophyton mentagrophytes , 1985, Antimicrobial Agents and Chemotherapy.

[9]  H. Jones,et al.  Griseofulvin-resistant dermatophytosis correlates with in vitro resistance. , 1981, Archives of dermatology.

[10]  V. Shah,et al.  Griseofulvin levels in stratum corneum. Study after oral administration in man. , 1972, Archives of dermatology.